Edwards Lifesciences EW
NYSE EW
$87.21 +0.61 (+0.70%)
As of: Oct 19, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) Gains from Sales and Divestitures (2024 - 2025)

Updated

Edwards Lifesciences (EW) reported Gains from Sales and Divestitures of $33.9 million for Q4 2025, up 213.9% from $10.8 million a year earlier.

Analysis

Edwards Lifesciences (EW) Gains from Sales and Divestitures (2024 - 2025) Analysis & Trends

  • By year, Gains from Sales and Divestitures came in at $3.35 billion in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.93 Bn 230.96 Bn 4.88 Bn
2 Abbott Laboratories 181.29 Bn 151.72 Bn 7.27 Bn
3 Danaher 158.18 Bn 141.99 Bn 3.61 Bn
4 Intuitive Surgical 153.47 Bn 132.89 Bn 1.96 Bn
5 Medtronic 118.97 Bn 84.22 Bn 6.34 Bn
6 Stryker 114.72 Bn 100.84 Bn 4.50 Bn
7 Boston Scientific 66.18 Bn 60.95 Bn 3.85 Bn
8 Becton Dickinson 52.49 Bn 49.64 Bn 2.32 Bn
9 Edwards Lifesciences 50.32 Bn 34.33 Bn 1.35 Bn
10 Agilent Technologies 47.87 Bn 40.76 Bn 1.04 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 33.90 Mn
Dec 31, 2024 10.80 Mn
API Access

Edwards Lifesciences Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=EW&period=max&api_key=YOUR_API_KEY